Will those crazy kids manage to make it work? Unclear.

Teoxane withdrew its $3.60 a share offer for Revance Therapeutics after Crown Labs raised its offer to $3.65. Revance ticked lower by 0.3% in premarket trading. Teoxane said that committed financing ...

Geoffrey Zakarian's newsletter helped him build direct relationships with his audience, turning fans into customers.